Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis

BACKGROUND: Optimal biomarkers to select patients who will benefit most from immunotherapy remain lacking in nasopharyngeal cancer (NPC). This systematic review and meta-analysis aimed to evaluate the association between various biomarkers and clinical outcomes in NPC patients treated with immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiaoyan, Chen, Haizhu, Tao, Yunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102485/
https://www.ncbi.nlm.nih.gov/pubmed/37063822
http://dx.doi.org/10.3389/fimmu.2023.1146898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102485/
https://www.ncbi.nlm.nih.gov/pubmed/37063822
http://dx.doi.org/10.3389/fimmu.2023.1146898

Ejemplares similares